Sacubitril/valsartan as a Treatment for Resistant Hypertension in Patients With Heart Failure and Preserved Ejection Fraction

被引：0
|
作者：
Jhund, Pardeep S.
Alice, M.
Pfeffer, Marc A.
Zannad, Faiez
Lefkowitz, Martin P.
Shi, Victor
Vardeny, Orly
Solomon, Scott
McMurray, John J.
机构：
来源：
CIRCULATION | 2020年 / 142卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16477
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction
    Jackson, Alice M.
    Jhund, Pardeep S.
    Anand, Inder S.
    Duengen, Hans-Dirk
    Lam, Carolyn S. P.
    Lefkowitz, Marty P.
    Linssen, Gerard
    Lund, Lars H.
    Maggioni, Aldo P.
    Pfeffer, Marc A.
    Rouleau, Jean L.
    Saraiva, Jose F. K.
    Senni, Michele
    Vardeny, Orly
    Wijkman, Magnus O.
    Yilmaz, Mehmet B.
    Saito, Yoshihiko
    Zile, Michael R.
    Solomon, Scott D.
    McMurray, John J., V
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 (36) : 3741 - +
  • [2] Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction
    Butt, Jawad H.
    Dewan, Pooja
    Jhund, Pardeep S.
    Anand, Inder S.
    Atar, Dan
    Ge, Junbo
    Desai, Akshay S.
    Echeverria, Luis E.
    Kober, Lars
    Lam, Carolyn S. P.
    Maggioni, Aldo P.
    Martinez, Felipe
    Packer, Milton
    Rouleau, Jean L.
    Sim, David
    Van Veldhuisen, Dirk J.
    Vrtovec, Bojan
    Zannad, Faiez
    Zile, Michael R.
    Gong, Jianjian
    Lefkowitz, Martin P.
    Rizkala, Adel R.
    Solomon, Scott D.
    McMurray, John J., V
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : 1130 - 1143
  • [3] Sacubitril/valsartan for heart failure with preserved ejection fraction and resistant hypertension: one shot for a double strike?
    Volpe, Massimo
    Gallo, Giovanna
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 (36) : 3753 - 3755
  • [4] Making the case for sacubitril/valsartan in patients with heart failure with a preserved ejection fraction
    Tai, Andrew
    Ambrosy, Andrew P.
    Fudim, Marat
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (03) : E5 - E6
  • [5] Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction
    Raschi, Emanuel
    Diemberger, Igor
    Sabatino, Mario
    Poluzzi, Elisabetta
    De Ponti, Fabrizio
    Potena, Luciano
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (03) : 303 - 320
  • [6] Reduction of Pulmonary Hypertension After Transition to Sacubitril/Valsartan in Patients With Heart Failure With Preserved Ejection Fraction
    Burgdorf, Christof
    Brockmoeller, Janine
    Strampe, Henrieke
    Januszewski, Monika
    Remppis, Bjoern Andrew
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [7] Sacubitril/valsartan in an experimental model of heart failure with preserved ejection fraction
    De Angelis, A.
    Cappetta, D.
    Telesca, M.
    Bellocchio, G.
    Urbanek, K.
    Berrino, L.
    [J]. CARDIOVASCULAR RESEARCH, 2022, 118 (SUPPL 1)
  • [8] EFFICACY OF SACUBITRIL/VALSARTAN INMAINTENANCE HEMODIALYSIS PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Fu, Sha
    Wang, Xiaohong
    Song, Qirong
    Chen, Junzhe
    Tang, Ying
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I161 - I162
  • [9] Sacubitril/valsartan for patients with heart failure with preserved ejection fraction: what will the FDA decide?
    McMurray, John J. V.
    [J]. KARDIOLOGIA POLSKA, 2021, 79 (01) : 104 - 105
  • [10] Sacubitril/Valsartan in heart failure with preserved ejection fraction in women and lower-range preserved ejection fraction
    Dachs, T.
    Nagele, F.
    Rettl, R.
    Dalos, D.
    Duca, F.
    Binder-Rodriguez, C.
    Camuz-Ligios, L.
    Dusik, F.
    Seirer, B.
    Hengstenberg, C.
    Bonderman, D.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S206 - S207
12345